How Much Do You Really Know About the Flu?

Yesterday, after giving a talk on social media to a great NYC-based PR firm called Ricochet,I decided to take an uptown trip to visit Professor Vincent Racaniello at Columbia University Medical School to talk about the new applications that we plan to introduce to BioCrowd.

When I arrived at Professor Racaniello’s office, which has an outstanding view of the Hudson River and George Washington Bridge, he was in the middle of taping this week’s This Week in Virology (TWiV) podcast with co-hosts Dick Despommier and Alan Dove. Much to my surprise, Vincent invited me to join the conversation although I am a bacteriologist not a virologist. The podcast was devoted mainly to answering questions that listeners had submitted to the show. One listener alerted us to a post at Newsweek Online entitled “Fight Flu and Falsehoods” while we didn’t agree with the author’s assertion that “that hand washing doesn’t affect the transmissibility of influenza”—it does reduce infections rates of other viruses, bacteria and parasites, so it is a good idea to continue to wash your hands—accompanying the article was an outstanding online quiz that assesses how much you really know about influenza and other viruses. 

I think it would be fun for BioJobBlog readers to take the quiz, report scores and then tabulate the results.

To take the quiz, click here and to report your score click here!  I will tabulate the results and share them in a later post if enough BioJobBlog readers and their friends take!

Until next time

Good Luck and More Luck On the Quiz!!!

 

Podcast Alert: BioCrowd Founder Talks about Using Recruiters to Find Jobs in the Life Sciences Industry

Have you ever received a call from a “head hunter” who suggests that they might be able to assist you in your job search? Can professional recruiters actually help you find a job? Finally, have you ever wondered what’s in it for the recruiter if they don’t charge jobseekers a fee to help them with their job searches?

If you are curious about these and other questions, please listen to a podcast  of BioCrowd founder Cliff Mintz's interview with Romi Kher, the host of Cornell University’s 10GoodMinutes ,a talk show that provides career advice for young professionals.

Until next time...

Good Luck and Good Job Hunting!!!

 SocialTwist Tell-a-Friend

 

Are You Ready for Your Interview?

When the job market gets tough, it is the “little things” that can make the difference between a job offer and a rejection letter. As you all know by now, face-to-face interviews are the “make or break” event in any job search. To that end, any edge that you can get may make the difference between being employed or receiving unemployment benefits in today’s job market. Although I am not a big fan of quizzes or surveys, it may be worth the time to take an ‘interview preparedness’ quiz that I found on Monster.com. I want to state upfront that I didn’t take the quiz nor can I vouch for its accuracy. That said, remember; it is the little things that frequently determine your fate at job interviews. 

Let me know how you fared!

Until next time…

Good Luck and Good Job Hunting!!!!!!!!

More Interviewing Tips

I happened upon this article that expands upon some of the interviewing ideas and tips that I presented in previous posts. The piece was written by someone from Business Week so it must relevant and might even be worth reading! 

Until next time….

Good Luck and Good Job Hunting!!!!!!!!

Peggy McKee: It's YOUR turn to ask the questions

There’s a ton of stuff online about what kinds of interview questions to expect, and how to answer them to impress the interviewer.  But, you have to remember (and it does wonders for your confidence if you do) that you’re interviewing them, also.  You need to find out if this is a medical sales company that you’re going to be happy working for.  So, what kinds of questions should you ask?  Here’s an article on 10 Questions to Dazzle Would-Be Employers to help you.  Some of my favorites:

“How do you see me benefitting the company?”  Find out what caught their eye about you in the first place, and then you can bring up those qualities for a better sell.

“Why did you choose this company?”  If they haven’t tried to sell you on the company already, this answer gives you some insight.

“When will a decision be made?”  Suprisingly, many people don’t ask that, and end up frustrated if it takes longer than they were expecting. 

Your questions about the company and the job will set you apart from other candidates and show how interested you are in the position.  Not to mention it will give you extra insight into your decision whether or not to work for them.

If you have any  questions for Peggy aka the Medical Sales Recruiter contac her  at: the medical sales recruiter blog!

Until next time.....

Good Luck and Good Job Hunting!!!!!!!!!!

The Top 10 Interview Questions That You Hate to Answer!

During the course of my 25 years or so of participating in job interviews, I have come across a variety of questions that interviewers seem to routinely ask interviewees. While some of the questions may seem silly or ridiculous, according to interviewing etiquette and protocol (and how much you want the job) you are required to answer them. The intent of many of these questions is not to be flippant or intrusive but to determine whether a candidate can think quickly on his/her feet or field difficult questions that they may encounter as an employee.

An appropriate response to difficult interview questions (that appear to be personal or overly intrusive) is to couch your responses in the context of the position rather than revealing your true feelings or motivations.  For example, if an interviewer asks: “Why are you looking for a new job”? An appropriate answer may be: “I am seeking new opportunities and challenges and I believe that I can find them at your company”. Don’t say: “My funding is running out or I can’t stand my boss anymore or I hate what I am currently doing.” In this instance, the interviewer isn’t really asking about your personal reasons or motives for looking for a new job or leaving an old one. He/she is probing to determine what your level of interest is in the job and whether you will be able to get along with employees who are already working for the company.

In my opinion, the best way to deal with personal or difficult interview questions is to be aware that they exist and to prepare “canned” answers for them. That said, I suggest that you carefully review the list of questions below and design well-crafted responses to each of them. Further, I think it is a good idea to conduct “mock interviews” with friends or colleagues to determine whether the responses that you crafted are sufficient and convincing enough. In my experiences, friends and colleagues have always been good barometers for the answers that I came up with. Hint: If they start laughing uncontrollably or look shocked or dismayed after you have answered a question, it may be a good idea to come up with a new answer.

While you may not be asked all of the questions on the list, I am willing to bet that you will be asked at least one of them!

TOP 10 INTERVIEW QUESTIONS LIST

10.      Describe how you overcame adversity in your life

 9.       Tell me about your most disappointing experience

 8.       Tell me about your greatest achievements

 7.       Why are you looking for a new job?

 6.       Are you willing to relocate?

 5.       May I contact your current employer?

 4.       Why this company and not our competitors?

 3.       What are your weaknesses?

 2.       What are your strengths?

 1.       Where do you see yourself five years from now?

Please feel free to send me any questions that you may have been asked if they don’t already appear on the list! 

Until next time….

Good Luck and Good Job Hunting!!!!!!!!

The Demise of RNAi?

There is mounting evidence that RNAi, once hailed as a panacea for the pharmaceutical and biotechnology industries, may not be all that it was claimed to be. Yes, there are several new RNAi drug candidates in late stage clinical development but it isn’t clear, at this point, whether any of these products will ever make it to market. Companies like Allergan, Alnylam, Opko Health and Merck, which recently bought the RNAi company Sirna Therapeutics for $1.1 billion, have invested hundreds of millions of dollars and literally “bet the farm” on RNAi therapeutics.

The use of DNA and RNA as therapeutics is not a new or novel idea. Isis Pharmaceuticals, a pioneer and champion of oligonucleotide therapeutics, has only be able to bring a single, oligonucleotide-based product to market in the past 20 years. Ask any Isis executive and they will tell you that turning DNA or RNA into drugs is a challenging process that is fraught with many difficulties. Most notably, there are bioavailability, delivery and target specificity hurdles that most be over come before the utility of these drugs as therapeutic agents can be realized. That said the attractiveness of these molecules as therapeutics (and perhaps their real danger) is the simplicity and elegance of their mechanism(s) of action. Most scientists tend to “fall in love” with elegant and parsimonious solutions to complex processes—why would we not, they are type of discoveries that we all train and live for! And, as many of us know, when people “fall in love”, there is a tendency to overlook or not notice warning signs that things may not be as they seem.

The scientific community fell quickly and deeply in love with RNAi soon after the first papers appeared touting its benefits and possible therapeutic applications. Scientists were so convinced and confident about RNAi that they induced the financial community to invest billions of dollars into the emerging technology. The love and affection for RNAi reached its pinnacle in 2006 when two scientists, who played a crucial role in discovering its mechanism of action, won the Nobel Prize. Since then, the harsh realities of RNAi drug development have begun to be realized by companies that invested in the technology.

I have been around long enough to understand that there are fads in science. In the mid 1990s it was combinatorial chemistry, in the late 1990s it was genomics, proteomics and computational chemistry and in the 2000s it is RNAi. Don’t get me wrong–all of these technologies have helped to advance science and  provide researchers with sophisticated tools that have helped to expedite the drug discovery and development process. That said, none of these technologies, by themselves, yielded the plethora of new medications or therapeutics that their advocates promised. Industry veterans know that there are no easy solutions or panaceas in drug discovery and development. The process is inherently time-intensive, painstaking and tedious. And, despite what we scientists want to believe in our “heart of hearts,” there are no guarantees that simplicity and elegance will translate into safe and effective medications.

Until next time….

Good Luck and Good Job Hunting!!!!!!!!!!